Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

被引:70
作者
Haines, David E. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha [2 ]
机构
[1] Oakland Univ, Dept Cardiovasc Med, William Beaumont Sch Med, Beaumont Hosp,Heart Rhythm Ctr, Royal Oak, MI 48073 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
关键词
complications; death; implantable cardioverter-defibrillators; outcome assessment; registries; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; PACEMAKER; OUTCOMES;
D O I
10.1161/CIRCULATIONAHA.110.959676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Patients undergoing implantable cardioverter-defibrillator (ICD) implantation are at risk of postprocedural complications. However, we do not have a risk stratification schema to identify patients at high and low risk of adverse events. Methods and Results-We analyzed data from 268 701 ICD implants submitted to the ICD Registry and developed logistic regression models to identify variables most strongly associated with the risk of acute complications and/or in-hospital death. Overall, 3.2% of the population experienced an adverse event. A simple risk score consisting of 10 readily available variables successfully identified patients at high and low risk of complications. The variables included in the score and assigned points included: age >= 70 years (1 point), female (2 points), New York Heart Association class III (1 point) or IV (3 points), atrial fibrillation (1 point), prior valve surgery (3 points), chronic lung disease (2 points), blood urea nitrogen >30 (2 points), reimplantation for reasons other than battery change (6 points), ICD type dual chamber (2 points) or biventricular (4 points), and nonelective ICD implant (3 points). The risk of any in-hospital complication increased from 0.6% among patients with a score of <= 5 (8.4% of the population) to 8.4% among patients with >= 19 risk points (3.9% of the population). Conclusions-A simple risk score consisting of readily available clinical variables can identify high-and low-risk subsets of patients undergoing ICD implantation. This information can guide the physician in patient selection and determining the intensity of care required post procedure. (Circulation. 2011;123:2069-2076.)
引用
收藏
页码:2069 / 2076
页数:8
相关论文
共 24 条
[1]  
Al-Khatib SM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P240, DOI 10.1161/CIRCEP.108.777888
[2]   The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries [J].
Al-Khatib, SM ;
Lucas, FL ;
Jollis, JG ;
Malenka, DJ ;
Wennberg, DE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1536-1540
[3]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[4]   Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone [J].
Connolly, SJ ;
Gent, M ;
Roberts, RS ;
Dorian, P ;
Roy, D ;
Sheldon, RS ;
Mitchell, LB ;
Green, MS ;
Klein, GJ ;
O'Brien, B .
CIRCULATION, 2000, 101 (11) :1297-1302
[5]   Implantable cardioverter-defibrillators [J].
DiMarco, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19) :1836-1847
[6]   Complications associated with pectoral cardioverter-defibrillator implantation: Comparison of subcutaneous and submuscular approaches [J].
Gold, MR ;
Peters, RW ;
Johnson, JW ;
Shorofsky, SR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (05) :1278-1282
[7]   Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories [J].
Gould, PA ;
Krahn, AD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (16) :1907-1911
[8]   NATIONAL ICD REGISTRY ANNUAL REPORT 2008 Review of the ICD Registry's Third Year, Expansion to include Lead Data and Pediatric ICD Procedures, and Role for Measuring Performance [J].
Hammill, Stephen C. ;
Kremers, Mark S. ;
Kadish, Alan H. ;
Stevenson, Lynne Warner ;
Heidenreich, Paul A. ;
Lindsay, Bruce D. ;
Mirro, Michael J. ;
Radford, Martha J. ;
McKay, Chuck ;
Wang, Yongfei ;
Lang, Christine M. ;
Pontzer, Kathryn ;
Rumsfed, John ;
Phurrough, Steve E. ;
Curtis, Jeptha P. ;
Brindis, Raph G. .
HEART RHYTHM, 2009, 6 (09) :1397-1401
[9]   Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995 [J].
Hlatky, MA ;
Saynina, O ;
McDonald, KM ;
Garber, AM ;
McClellan, MB .
AMERICAN HEART JOURNAL, 2002, 144 (03) :397-403
[10]  
Hosmer W., 2000, Applied Logistic Regression, VSecond